Page last updated: 2024-08-24

sertraline and Huntington Disease

sertraline has been researched along with Huntington Disease in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (12.50)18.2507
2000's3 (37.50)29.6817
2010's4 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hult Lundh, S; Kirik, D; Nilsson, N; Petersén, Å; Soylu, R1
Deshmukh, R; Gill, JS; Jamwal, S; Kumar, P1
Chan, G; Chevarin, C; Du, X; Hannan, AJ; Lanfumey, L; Leang, L; Pang, TY; Renoir, T; Zajac, MS1
Chevarin, C; Du, X; Hannan, AJ; Lanfumey, L; Leang, L; Pang, TY; Renoir, T; Zajac, MS1
Brüne, M; Patzold, T1
Duan, W; Jiang, M; Li, Q; Masuda, N; Peng, Q; Ross, CA; Zhao, M1
Cadet, JL; Duan, W; Ford, E; Ladenheim, B; Masuda, N; Peng, Q; Ross, CA; Tryggestad, E; Wong, J; Zhao, M1
Lipsey, JR; Ranen, NG; Ross, CA; Treisman, G1

Other Studies

8 other study(ies) available for sertraline and Huntington Disease

ArticleYear
Hypothalamic expression of mutant huntingtin contributes to the development of depressive-like behavior in the BAC transgenic mouse model of Huntington's disease.
    Human molecular genetics, 2013, Sep-01, Volume: 22, Issue:17

    Topics: Animals; Anxiety; Behavior, Animal; Depression; Disease Models, Animal; Female; Humans; Huntingtin Protein; Huntington Disease; Hypothalamus; Male; Mice; Mice, Transgenic; Nerve Tissue Proteins; Neuropeptide Y; Receptors, Tachykinin; Sertraline; Vesicular Monoamine Transport Proteins

2013
Sertraline and venlafaxine improves motor performance and neurobehavioral deficit in quinolinic acid induced Huntington's like symptoms in rats: Possible neurotransmitters modulation.
    Pharmacological reports : PR, 2017, Volume: 69, Issue:2

    Topics: Animals; Corpus Striatum; Disease Models, Animal; gamma-Aminobutyric Acid; Glutamic Acid; Huntington Disease; Interleukin-1beta; Interleukin-6; Lipid Peroxidation; Male; Motor Activity; Neuroprotective Agents; Neurotransmitter Agents; Oxidative Stress; Quinolinic Acid; Rats; Rats, Wistar; Rotarod Performance Test; Sertraline; Tumor Necrosis Factor-alpha; Venlafaxine Hydrochloride

2017
Treatment of depressive-like behaviour in Huntington's disease mice by chronic sertraline and exercise.
    British journal of pharmacology, 2012, Volume: 165, Issue:5

    Topics: Animals; Antidepressive Agents; Behavior, Animal; Cell Proliferation; Depressive Disorder; Disease Models, Animal; Female; Gene Expression; Hippocampus; Huntington Disease; Mice; Mice, Transgenic; Physical Conditioning, Animal; Receptor, Serotonin, 5-HT1A; Receptor, Serotonin, 5-HT2A; Serotonin 5-HT1 Receptor Agonists; Serotonin 5-HT2 Receptor Agonists; Sertraline; Swimming

2012
Sexually dimorphic serotonergic dysfunction in a mouse model of Huntington's disease and depression.
    PloS one, 2011, Volume: 6, Issue:7

    Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Behavior, Animal; Depression; Disease Models, Animal; Feeding Behavior; Female; Gene Expression Regulation; Huntington Disease; Hydroxyindoleacetic Acid; Hyperthermia, Induced; Male; Mice; Mutation; Raphe Nuclei; Receptor, Serotonin, 5-HT1A; Receptor, Serotonin, 5-HT2A; Serotonin; Sertraline; Sex Characteristics; Swimming

2011
Obsessive compulsive disorder in huntington disease: a case of isolated obsessions successfully treated with sertraline.
    Neuropsychiatry, neuropsychology, and behavioral neurology, 2002, Volume: 15, Issue:3

    Topics: Adult; Female; Humans; Huntington Disease; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome

2002
The antidepressant sertraline improves the phenotype, promotes neurogenesis and increases BDNF levels in the R6/2 Huntington's disease mouse model.
    Experimental neurology, 2008, Volume: 210, Issue:1

    Topics: Age Factors; Animals; Antidepressive Agents; Behavior, Animal; Brain; Brain-Derived Neurotrophic Factor; Bromodeoxyuridine; Cell Proliferation; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Huntington Disease; Male; Mice; Mice, Transgenic; Motor Activity; Nerve Tissue Proteins; Neurons; Phenotype; Sertraline

2008
Sertraline slows disease progression and increases neurogenesis in N171-82Q mouse model of Huntington's disease.
    Neurobiology of disease, 2008, Volume: 30, Issue:3

    Topics: Animals; Asparagine; Cell Differentiation; Cell Movement; Disease Models, Animal; Disease Progression; Glutamine; Huntington Disease; Male; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Transgenic; Neurons; Sertraline

2008
Sertraline in the treatment of severe aggressiveness in Huntington's disease.
    The Journal of neuropsychiatry and clinical neurosciences, 1996,Summer, Volume: 8, Issue:3

    Topics: 1-Naphthylamine; Adult; Aggression; Female; Humans; Huntington Disease; Irritable Mood; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors; Sertraline

1996